ICON’s Oncology Solution expedites every aspect of a cancer drug trial. It combines global experience in all Phases of oncology drug development with expertise in tumor imaging, laboratory (including PK/PD and Biomarkers) IVRS, central data management , electronic data capture and regulatory oncology issues.

Our clinical trial experience includes the following oncology indications:

The in-depth therapeutic and operational knowledge of ICON’s Scientific Council and Oncology Centre of Excellence spans the entire drug development process. The Scientific Council provides scientific oversight and direction while the Centre of Excellence focuses on operational and training support of ICON’s project teams executing oncology studies.  Senior members of these groups have extensive haematology and oncology drug development and have worked on a wide variety of oncology programs and drug classes, including:
 

Our global investigator database includes thousands of oncology investigative sites worldwide. As such, ICON has close working relationships and consulting agreements with physicians at most of the major tertiary and academic cancer treatment centers as well as cooperative groups and consortiums. These extensive and well-established relationships provide ICON with the ability to obtain information quickly and concisely regarding development issues in oncology and effective recruitment strategies.